FLML Share Price

Open 10.73 Change Price %
High 11.03 1 Day 0.23 2.14
Low 10.73 1 Week 0.09 0.83
Close 10.99 1 Month 1.39 14.48
Volume 146583 1 Year -3.63 -24.83
52 Week High 15.54
52 Week Low 7.56
FLML Important Levels
Resistance 2 11.27
Resistance 1 11.15
Pivot 10.92
Support 1 10.83
Support 2 10.71
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.67 0.17%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OPXAW 0.01 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

Flamel Technologies S.A. (NASDAQ: FLML)

FLML Technical Analysis 3
As on 2nd Dec 2016 FLML Share Price closed @ 10.99 and we RECOMMEND Sell for LONG-TERM with Stoploss of 11.26 & Sell for SHORT-TERM with Stoploss of 11.69 we also expect STOCK to react on Following IMPORTANT LEVELS.
FLML Target for December
1st Target up-side 11.81
2nd Target up-side 12.64
3rd Target up-side 13.47
1st Target down-side 9.43
2nd Target down-side 8.6
3rd Target down-side 7.77
FLML Other Details
Segment EQ
Market Capital 83873160.00
Sector Healthcare
Industry Drug Delivery
Offical website http://www.flamel-technologies.fr
FLML Address
FLML
Parc Club du Moulin
33, avenue du Docteur Georges Levy
V, 69693
France
Phone: 33 472 78 34 34
Fax: 33 472 78 34 35
FLML Latest News
Interactive Technical Analysis Chart Flamel Technologies S.A. ( FLML NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Flamel Technologies S.A.
FLML Business Profile
Flamel Technologies SA has a pipeline of niche specialty pharmaceutical products. The Company�s drug delivery platforms are focused on developing safer, more efficacious formulations of drugs to address unmet medical needs. Its pipeline includes biological and chemical drugs formulated with its Medusa and Micropump (and its applications to the development of liquid formulations, which is LiquiTime and of abuse-deterrent formulations Trigger Lock) drug delivery platforms. It has collaborations with a number of pharmaceutical and biotechnology companies, including GlaxoSmithKline (Coreg CR, carvedilol phosphate). Its Medusa is based on a hydrophilic biodegradable polyglutamate chain grafted with hydrophobic Vitamin E. The Company�s LiquiTime allows the development of oral controlled release liquid formulations of drugs for patients who have difficulty swallowing tablets or capsules, such as children and the elderly.